Literature DB >> 10794742

Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization.

C J Fuery1, H L Impey, N J Roberts, T L Applegate, R L Ward, N J Hawkins, C A Sheehan, R O'Grady, A V Todd.   

Abstract

BACKGROUND: Restriction endonuclease-mediated selective (REMS)-PCR, allows detection of point mutations, deletions, and insertions. Reactions require concurrent activity of a restriction endonuclease (RE) and a DNA polymerase, both of which must be sufficiently thermostable to retain activity during thermocycling. The inclusion of the RE in REMS-PCR inhibits amplification of sequences containing the RE recognition site, thus producing selective amplification of sequences that lack the RE site.
METHODS: Assays were used that allowed the selection of conditions that produce concurrent RE/DNA polymerase activity. The RE thermostability assay involved thermocycling a RE under various conditions and assessing residual cleavage activity at various time points. Conditions found to preserve RE activity during thermocyling were then tested for their compatibility with DNA polymerase-mediated PCR.
RESULTS: A range of conditions that preserve activity of the RE BstNI over 30 cycles of PCR was identified. A subset of these conditions was subsequently found to mediate specific amplification using Taq DNA polymerase. These conditions were used to develop a REMS-PCR protocol for the detection of mutations at codon 12 of the K-ras gene. This protocol allowed the detection of 1 mutant allele in a background of 1000 wild-type alleles. The presence of primer sets for RE and PCR control amplicons provided unambiguous assessment of mutant status.
CONCLUSION: Implementation of the assays described may facilitate development of REMS-PCR assays targeted to other loci associated with disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794742

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Selective 'stencil'-aided pre-PCR cleavage of wild-type sequences as a novel approach to detection of mutant K-RAS.

Authors:  A V Lichtenstein; O I Serdjuk; T I Sukhova; H S Melkonyan; S R Umansky
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

2.  One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes.

Authors:  Karl Sotlar; Luis Escribano; Olfert Landt; Stefanie Möhrle; Sonia Herrero; Antonio Torrelo; Ulrich Lass; Hans-Peter Horny; Burkhard Bültmann
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

3.  Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Joseph L Wiemels; Michelle Kang; Jeffrey S Chang; Lily Zheng; Carina Kouyoumji; Luoping Zhang; Martyn T Smith; Ghislaine Scelo; Catherine Metayer; Patricia Buffler; John K Wiencke
Journal:  Blood Cells Mol Dis       Date:  2010-08-05       Impact factor: 3.039

4.  Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma.

Authors:  John A Tynan; Payam Mahboubi; Lesley L Cagasan; Dirk van den Boom; Mathias Ehrich; Paul Oeth
Journal:  J Mol Diagn       Date:  2011-05-06       Impact factor: 5.568

5.  Characterization of MspNI (G/GWCC) and MspNII (R/GATCY), novel thermostable Type II restriction endonucleases from Meiothermus sp., isoschizomers of AvaII and BstYI.

Authors:  Richa Gupta; Shuang-Yong Xu; Prince Sharma; Neena Capalash
Journal:  Mol Biol Rep       Date:  2011-12-23       Impact factor: 2.316

6.  Biotinylated probe isolation of targeted gene region improves detection of T790M epidermal growth factor receptor mutation via peptide nucleic acid-enriched real-time PCR.

Authors:  Jin Li; Pasi A Jänne; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2011-02-16       Impact factor: 8.327

7.  Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis.

Authors:  Matilde E Lleonart; Santiago Ramón y Cajal; John D Groopman; Marlin D Friesen
Journal:  Nucleic Acids Res       Date:  2004-03-22       Impact factor: 16.971

8.  Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses.

Authors:  Sara Mariani; Cristiana Di Bello; Lisa Bonello; Fabrizio Tondat; Donatella Pacchioni; Luca Molinaro; Antonella Barreca; Luigia Macrì; Luigi Chiusa; Paola Francia di Celle; Paola Cassoni; Anna Sapino
Journal:  PLoS One       Date:  2015-04-06       Impact factor: 3.240

9.  Mutation enrichment in human DNA samples via UV-mediated cross-linking.

Authors:  Ka Wai Leong; Fangyan Yu; G Mike Makrigiorgos
Journal:  Nucleic Acids Res       Date:  2022-04-08       Impact factor: 16.971

10.  FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations.

Authors:  Giulia Amicarelli; Erlet Shehi; G Mike Makrigiorgos; Daniel Adlerstein
Journal:  Nucleic Acids Res       Date:  2007-10-11       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.